Patents by Inventor Raymond Booth

Raymond Booth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240327353
    Abstract: 4-phenyl-2-dimethylaminotetralin compounds, formulations, and methods are provided for selective modulation of serotonin 5-HT2A and 5-HT2C receptors without causing sedation at doses that are antipsychotic. Mechanisms for selective modulation are shown to involve inverse agonism at one or more of the 5-HT2A-2C receptors based on stereochemistry and substituents. The technology can be targeted to receptors inside or outside the central nervous system.
    Type: Application
    Filed: July 14, 2022
    Publication date: October 3, 2024
    Inventor: Raymond BOOTH
  • Publication number: 20230348358
    Abstract: Compounds, compositions, and methods are provided for dual partial agonism of serotonin 5-HTS and 5-HTIA receptors. The enantiomerically pure 5-phenyl-2-aminotetralin (5-PAT) compounds can be used to treat or prevent substance use disorder, opioid use disorder, addiction, anxiety, psychosis, depression, autism spectrum disorder, fragile X syndrome, neurological disorders, neuropsychiatric disorders, repetitive behaviors, movement disorders, compulsions, tics, pain disorders, vasospastic disorders, migraine headache, seizures, epilepsy, social anxiety, addiction withdrawal, drug withdrawal, drug abuse, alcoholism, eating disorders, general inflammation disorders, miosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, and gastrointestinal disorders.
    Type: Application
    Filed: August 19, 2021
    Publication date: November 2, 2023
    Inventor: Raymond BOOTH
  • Patent number: D348202
    Type: Grant
    Filed: April 2, 1991
    Date of Patent: June 28, 1994
    Inventor: Raymond Booth